For GLP-1s specifically, because they tend to have such an outsize impact on prescription spending, its a good idea to have a pharmacist assist in evaluating them
Maridebart cafraglutide (previously known as AMG133) is a bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR antagonist antibody to two GLP-1 analogue agonist peptides using amino acid linkers
Dental concerns Lesser known effects of weight-loss drugs such as chronic dry mouth, nausea and vomiting can cause enamel erosion, tooth decay, increased sensitivity and gum issues
However, chewing and tasting food stimulate saliva production
Only injectable semaglutide has this data
New data from the Institute of Grocery Distribution (IGD)s latest quarterly report show the proportion of UK adults using medications such as Wegovy and Ozempic has nearly doubled in nine months, rising from 3.1% in June 2025 to 6% in March 2026